Endurance Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $2.77M | Buy |
5,914
+3,000
| +103% | +$1.26M | 0.38% | 57 |
|
|
2023
Q1 | $1M | Buy |
2,914
+266
| +10% | +$89.7K | 0.14% | 94 |
|
|
2022
Q4 | $969K | Buy |
2,648
+4
| +0.2% | +$1.42K | 0.15% | 92 |
|
|
2022
Q3 | $855K | Hold |
2,644
| – | – | 0.14% | 95 |
|
|
2022
Q2 | $857K | Hold |
2,644
| – | – | 0.13% | 99 |
|
|
2022
Q1 | $757K | Sell |
2,644
-1,029
| -28% | -$265K | 0.1% | 110 |
|
|
2021
Q4 | $1.01M | Sell |
3,673
-2
| -0.1% | -$507 | 0.11% | 117 |
|
|
2021
Q3 | $849K | Sell |
3,675
-400
| -10% | -$98.7K | 0.09% | 122 |
|
|
2021
Q2 | $935K | Hold |
4,075
| – | – | 0.1% | 122 |
|
|
2021
Q1 | $761K | Hold |
4,075
| – | – | 0.09% | 125 |
|
|
2020
Q4 | $688K | Hold |
4,075
| – | – | 0.09% | 124 |
|
|
2020
Q3 | $603K | Sell |
4,075
-66
| -2% | -$10.2K | 0.09% | 119 |
|
|
2020
Q2 | $680K | Buy |
4,141
+66
| +2% | +$10.1K | 0.11% | 109 |
|
|
2020
Q1 | $565K | Hold |
4,075
| – | – | 0.11% | 114 |
|
|
2019
Q4 | $536K | Hold |
4,075
| – | – | 0.08% | 128 |
|
|
2019
Q3 | $456K | Hold |
4,075
| – | – | 0.08% | 133 |
|
|
2019
Q2 | $451K | Hold |
4,075
| – | – | 0.07% | 132 |
|
|
2019
Q1 | $529K | Hold |
4,075
| – | – | 0.09% | 124 |
|
|
2018
Q4 | $472K | Hold |
4,075
| – | – | 0.09% | 122 |
|
|
2018
Q3 | $437K | Hold |
4,075
| – | – | 0.07% | 132 |
|
|
2018
Q2 | $348K | Hold |
4,075
| – | – | 0.06% | 142 |
|
|
2018
Q1 | $315K | Hold |
4,075
| – | – | 0.05% | 148 |
|
|
2017
Q4 | $344K | Hold |
4,075
| – | – | 0.06% | 140 |
|
|
2017
Q3 | $349K | Hold |
4,075
| – | – | 0.06% | 138 |
|
|
2017
Q2 | $335K | Hold |
4,075
| – | – | 0.06% | 140 |
|
|
2017
Q1 | $343K | Hold |
4,075
| – | – | 0.06% | 137 |
|
|
2016
Q4 | $300K | Hold |
4,075
| – | – | 0.05% | 139 |
|
|
2016
Q3 | $338K | Hold |
4,075
| – | – | 0.06% | 136 |
|
|
2016
Q2 | $321K | Hold |
4,075
| – | – | 0.06% | 132 |
|
|
2016
Q1 | $293 | Hold |
4,075
| – | – | 0.04% | 141 |
|
|
2015
Q4 | $343K | Buy |
4,075
+75
| +2% | +$6.22K | 0.07% | 135 |
|
|
2015
Q3 | $318K | Hold |
4,000
| – | – | 0.06% | 141 |
|
|
2015
Q2 | $334K | Hold |
4,000
| – | – | 0.06% | 140 |
|
|
2015
Q1 | $290K | Hold |
4,000
| – | – | 0.05% | 152 |
|
|
2014
Q4 | $275K | Hold |
4,000
| – | – | 0.05% | 150 |
|
|
2014
Q3 | $259K | Hold |
4,000
| – | – | 0.05% | 149 |
|
|
2014
Q2 | $248K | Hold |
4,000
| – | – | 0.04% | 153 |
|
|
2014
Q1 | $235K | Hold |
4,000
| – | – | 0.05% | 145 |
|
|
2013
Q4 | $204K | Hold |
4,000
| – | – | 0.04% | 150 |
|
|
2013
Q3 | $201K | Buy |
+4,000
| New | +$209K | 0.04% | 142 |
|
Other funds holding LLY
Endurance Wealth Management's LLY Position: Q2 2023 in Review
Endurance Wealth Management increased its Eli Lilly (LLY) stake by 103% in Q2 2023, buying an estimated $1.26M and bringing the position to 5,914 shares worth $2.77M. The position accounts for 0.38% of the portfolio, ranked #57.
Endurance Wealth Management first reported a position in LLY in Q3 2013 and has held it in 40 quarters since. 2,815 funds tracked by Wall St. Rank hold LLY as of Q2 2023.
- Endurance Wealth Management held 5,914 shares of Eli Lilly worth $2.77M as of Q2 2023.
- Endurance Wealth Management bought 3,000 Eli Lilly shares in Q2 2023, an estimated $1.26M.
- Eli Lilly made up 0.38% of Endurance Wealth Management's portfolio in Q2 2023, its #57 holding.
- Endurance Wealth Management first reported a position in Eli Lilly in Q3 2013 and has held it in 40 quarters since.
- 2,815 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2023.
Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.